IgA Nephropathy in a Patient with Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is an autoimmune disorder. One of the most typical aspects of SLE is renal involvement. Lupus nephritis is a serious disease whose prognosis can usually be improved dramatically by treatment. The occurrence of non-lupus nephritis in SLE patients has rarely been reported. IgA Nephropathy (IgAN) and lupus nephritis (LN) have quite different laboratory, histopathologic findings and extra-renal clinical manifestations. In the light of these data we thought that IgAN and LN have different pathogeneses. We report a patient with SLE in whom IgA nephropathy was diagnosed.

Özet

Sistemik lupus eritematoz (SLE) otoimmün bir hastalıktır. SLE'nin en tipik özelliklerinden birisi böbrek tutulumudur. Lupus nefriti ciddi bir hastalıktır ki prognozu genellikle tedavi ile önemli ölçüde geliştirilebilir. SLE hastalarında lupus nefriti dışı nefrit oluşumu nadiren bildirilmiştir. IgA Nefropatisi (IgAN) ve lupus nefritinin (LN) oldukça farklı laboratuvar, histopatolojik bulguları ve ekstrarenal klinik belirtileri vardır. Bu veriler ışığında IgAN ve LN'nin patogenezlerinin farklı olduğunu düşünmekteyiz. Burada biz IgAN'si tespit edilen SLE'li bir olgu sunacağız.

🔖

Cite This Article

DURANAY, M., ENSARİ, A., KARAKÖSE, S., ÜNVERDİ, S., KOÇ, E. (2022). IgA Nephropathy in a Patient with Systemic Lupus Erythematosus. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, Cilt: 25 - Sayı: 2, 205–207. https://ajindex.com/articles/636141

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Inman RD, Day NK: Immunologic and clinical aspects of immune complex disease. Am J Med 1981;70:1097-1106 2. Churg J, Bernstein J, Glassock RJ: Lupus nephritis. Renal Disease: Classification and Atlas of Glomerular Disease. (2nd ed). Tokyo: Igaku-Shoin, 1995; 151-155 3. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M; International Society of Nephrology Working Group on the Classification of Lupus Nephritis; Renal Pathology Society Working Group on the Classification of Lupus Nephritis: The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 2004;65:521-530 4. Verma RN, Banerjee AK, Bhattacharya K: Lupus nephritis-light, electron and immunofluorescent microscopy (a clinicopathological study). Indian J Pathol Microbiol 1989;32:246-251 5. Basile C, Semeraro A, Montanaro A, Giordano R, De Padova F, Marangi AL, Ligorio VA, Santese D: IgA nephropathy in a patient with systemic lupus erythematosus. Nephrol Dial Transplant 1998;13:1891-1892 6. D'Amico G: Natural history of idiopathic IgA nephropathy: Role of clinical and histological prognostic factors. Am J Kidney Dis 2000;36:227-237 7. Geddes CC, Rauta V, Gronhagen-Riska C, Bartosik LP, Jardine AG, Ibels LS, Pei Y, Cattran DC: A tricontinental view of IgA nephropathy. Nephrol Dial Transplant 2003;18:1541-1548 8. Lam GK, Petri M: Assessment of systemic lupus erythematosus. Clin Exp Rheumatol 2005;23:120-132 9. Corrado A, Quarta L, Di Palma AM, Gesualdo L, Cantatore FP: IgA nephropathy in systemic lupus erythematosus. Clin Exp Rheumat 2007;25:467-469 10. Miyazaki R, Kuroda M, Akiyama T, Otani I, Tofuku Y, Takeda R: Glomerular deposition and serum levels of complement control proteins in patients with IgA nephropathy. Clin Nephrol 1984;21:335-340 11. Chábová V, Tesar V, Zabka J, Rychlik I, Merta M, Jirsa M Jr, Stejskalová A: Long term treatment of IgA nephropathy with cyclosporine A. Ren Fail 2000;22:55-62